Eli Lilly will invest $4.5 billion to create the Lilly Medicine Foundry, which the drug giant says will be the first-ever ...
Life expectancy at birth has steadily increased around the world, with a significant 73% of this rise attributed to the ...
Brazilian researchers have topped a bioinformatics competition looking to find molecules that could one day function as ...
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new ...
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Roche Holding AG is aiming to deliver 20 new medicines to address diseases that rank among the biggest burdens to society ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...
RelateXR uses virtual reality to help recovering addicts envision the outcome of active addiction versus long-term recovery.
The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.
West Virginia's new drug czar has a very personal reason for wanting to end the state's opioid crisis: He was once addicted ...